Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) Target Price at $87.50
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been given a consensus rating of “Buy” by the ten research firms that are currently covering the stock, Marketbeat.com reports. Nine analysts ...
Instil Bio upgraded to Buy from Hold at Jefferies
Jefferies upgraded Instil Bio (TIL) to Buy from Hold with a price target of $52, up from $11.Don't Miss Our New Year's Offers:Discover the ...